Full Press Release Details
Release Details
Biogen Reports Second Quarter 2026 Results
July 29, 2026
Biogen Reports Second Quarter 2026 Results
358.3 KB
Stockholder Communications
E-mail Alerts
FAQs
Learn more about our Events & Presentations
BIIB Neutral Sentiment
Biogen Reports Second Quarter 2026 Results
Key Takeaway: Biogen has released its financial results for the second quarter of 2026. The report includes details relevant to stockholders and stakeholders. Further communications and presentations are available for those interested in the company's performance.
Price reaction · baseline $205.61 (2026-07-28 close) · hit pre-market · clean, no other BIIB news in the window
day 0 close
+1.8%
Market Sentiment Analysis
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+34%
120-day peak, hindsight
Typical move
1.8%
average across 15 past catalysts
Lead asset
Alefacept
Phase 3 · Chronic Plaque Psoriasis